US2017283151A1PendingUtilityA1

Medication system

Assignee: CARDINAL HEALTH COMMERCIAL TECH LLCPriority: Apr 1, 2016Filed: Mar 22, 2017Published: Oct 5, 2017
Est. expiryApr 1, 2036(~9.7 yrs left)· nominal 20-yr term from priority
G16H 20/10A61J 1/035G16H 40/67A61J 2200/30A61J 2205/60B65D 75/367B65D 79/00G06F 19/3456
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A medication system includes a blister pack. The blister pack includes a sheet containing a plurality of blisters each respectively containing at least one medication. The blister pack further includes a backing positioned on the sheet and a substrate layer having electronic circuitry thereon, the circuitry including traces terminating at one end at positions corresponding to each of the blisters. The blister pack is connected to an edge connector disposed adjacent to an edge of the sheet, the traces terminating at an other end to the edge connector. The medication system also includes a hub in electronic communication with the blister pack. The traces positioned such that each time a blister is punctured, the breakage event is communicated to the hub and recorded.

Claims

exact text as granted — not AI-modified
1 . A medication system, comprising:
 a blister pack including:
 a sheet containing a plurality of blisters each respectively containing at least one medication; 
 a backing positioned on the sheet and including a substrate layer having electronic circuitry thereon, the circuitry including traces terminating at one end at positions corresponding to each of the blisters; and 
 an edge connector disposed adjacent to an edge of the sheet, the traces terminating at an other end to the edge connector; and 
   a hub in electronic communication with the blister pack;   wherein the traces positioned such that each time a blister is punctured, the breakage event is communicated to the hub and recorded.   
     
     
         2 . The medication system of  claim 1 , wherein the edge connector is an electronic module that includes a communication device, a memory, a micro-controller, a clock, and a power source. 
     
     
         3 . The medication system of  claim 2 , wherein the communication device includes Wi-Fi, Bluetooth, Bluetooth Low-Energy (BLE), or Zigbee. 
     
     
         4 . The medication system of  claim 2 , wherein when a user punctures one of the blisters, the trace corresponding to the punctured blister sends a signal to the edge connector, whereby the clock within the edge connector records the time of the puncture in the memory, and the communication device sends a signal to the hub of the puncture.

Join the waitlist — get patent alerts

Track US2017283151A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.